Home > Cashflow Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Cashflow Statement

COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Profit Before Tax₹-233 Cr₹342 Cr₹120 Cr₹-161 Cr₹441 Cr
Adjustment ₹1,569 Cr₹1,373 Cr₹1,276 Cr₹1,136 Cr₹787 Cr
Changes In working Capital ₹527 Cr₹-488 Cr₹-234 Cr₹-302 Cr₹-292 Cr
Cash Flow after changes in Working Capital ₹1,863 Cr₹1,227 Cr₹1,161 Cr₹673 Cr₹936 Cr
Cash Flow from Operating Activities ₹1,653 Cr₹892 Cr₹1,005 Cr₹484 Cr₹766 Cr
Cash Flow from Investing Activities ₹-826 Cr₹-477 Cr₹-434 Cr₹-1,339 Cr₹-1,812 Cr
Cash Flow from Financing Activities ₹-39 Cr₹-441 Cr₹-422 Cr₹818 Cr₹794 Cr
Net Cash Inflow / Outflow ₹788 Cr₹-26 Cr₹148 Cr₹-37 Cr₹-251 Cr
Opening Cash & Cash Equivalents ₹182 Cr₹219 Cr₹53 Cr₹85 Cr₹262 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger ----₹77 Cr
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹6.35 Cr₹-11 Cr₹18 Cr₹5.15 Cr₹-2.04 Cr
Closing Cash & Cash Equivalent ₹976 Cr₹182 Cr₹219 Cr₹53 Cr₹85 Cr

Compare Cashflow Statement of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹22,891.7 Cr 2.3% 4.9% -14.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹465,507.0 Cr 2.8% 7.4% 14.5% Stock Analytics
DIVIS LABORATORIES ₹190,744.0 Cr 6.4% 8.3% 0.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹168,250.0 Cr 2.1% 8.7% 47.7% Stock Analytics
CIPLA ₹116,213.0 Cr 0.5% 3.6% -5.6% Stock Analytics
DR REDDYS LABORATORIES ₹103,980.0 Cr -7.6% -2.2% -5.8% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

2.3%

4.9%

-14.1%

SENSEX

-1.4%

4.4%

-7.6%


You may also like the below Video Courses